Cipla Limited (LUX:CIPLA)

Market Cap	10.76B
Revenue (ttm)	2.68B
Net Income (ttm)	522.05M
Shares Out	n/a
EPS (ttm)	0.65
PE Ratio	20.62
Forward PE	22.55
Dividend	0.12 (0.75%)
Ex-Dividend Date	Jun 26, 2025

Volume	n/a
Average Volume	n/a
Open	n/a
Previous Close	16.00
Day's Range	n/a
52-Week Range	15.90 - 18.90
Beta	n/a
RSI	31.14
Earnings Date	Jan 23, 2026

About Cipla

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer’s disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obe...

• Industry: Pharmaceutical Preparations
• Founded: 1935
• Employees: 30,313
• Stock Exchange: Luxembourg Stock Exchange
• Ticker Symbol: CIPLA

Financial Performance

In 2024, Cipla's revenue was 272.67 billion, an increase of 6.78% compared to the previous year's 255.37 billion. Earnings were 52.73 billion, an increase of 27.93%.

Financial numbers in INR